(19)
(11) EP 0 550 485 A1

(12)

(43) Date of publication:
14.07.1993 Bulletin 1993/28

(21) Application number: 91916067.0

(22) Date of filing: 21.09.1991
(51) International Patent Classification (IPC): 
A61K 39/ 21( . )
C07K 1/ 22( . )
C07K 14/ 16( . )
C12N 15/ 09( . )
C12P 21/ 02( . )
A61P 31/ 12( . )
C07K 14/ 00( . )
C07K 14/ 705( . )
C12N 15/ 49( . )
A61K 39/ 00( . )
(86) International application number:
PCT/EP1991/001810
(87) International publication number:
WO 1992/006113 (16.04.1992 Gazette 1992/09)
(84) Designated Contracting States:
AT BE CH DE DK ES FR GB GR IT LI LU NL SE

(30) Priority: 28.09.1990 GB 19900021175
21.03.1991 GB 19910006048

(60) Divisional application:
94202409.2 / 0644201

(71) Applicant: SMITHKLINE BEECHAM BIOLOGICALS s.a.
B-1330 Rixensart (BE)

(72) Inventors:
  • VAN WIJNENDALE, Frans
    B-3040 Ottenburg (BE)
  • SLAOUI, Moncef
    89, rue de l'Institut B-1330 Rixensart (BE)
  • BRUCK, Claudine
    89, rue de l'Institut B-1330 Rixensart (BE)
  • FRANCOTTE, Myriam
    89, rue de l'Institut B-1330 Rixensart (BE)
  • KUMMERT, Suzy
    89, rue de l'Institut B-1330 Rixensart (BE)

(74) Representative: Dalton, Marcus Jonathan William, et al 
SmithKline Beecham plc Corporate Intellectual Property SB House Great West Road
Brentford, Middlesex TW8 9BD
Brentford, Middlesex TW8 9BD (GB)

   


(54) DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT